|1.||Del Rosso, James Q: 5 articles (11/2010 - 01/2004)|
|2.||Feldman, Steven R: 2 articles (06/2014 - 01/2008)|
|3.||Fleischer, Alan B: 2 articles (11/2010 - 09/2009)|
|4.||Silapunt, Sirunya: 1 article (08/2015)|
|5.||Wolf, Kristin: 1 article (08/2015)|
|6.||Bartlett, Kyle B: 1 article (06/2014)|
|7.||Davis, Scott A: 1 article (06/2014)|
|8.||Wolf, Ronni: 1 article (01/2014)|
|9.||Tüzün, Yalçın: 1 article (01/2014)|
|10.||Engin, Burhan: 1 article (01/2014)|
|1.||Rosacea (Acne Rosacea)
03/01/2009 - "Treatment of papulopustular rosacea with sodium sulfacetamide 10%/sulfur 5% emollient foam."
01/01/2004 - "The combination of sodium sulfacetamide and sulfur is unique in the rosacea armamentarium because of its dual use as topical therapy and therapeutic cleanser. "
01/01/2004 - "Evaluating the role of topical therapies in the management of rosacea: focus on combination sodium sulfacetamide and sulfur formulations."
07/01/2005 - "At present, little data exists regarding the use of combination topical therapy in rosacea management, although anecdotal evidence and preliminary studies suggest at least some additive benefit when topical metronidazole is used in combination with sulfacetamide 10% /sulfur 5%. "
06/01/2005 - "Topical metronidazole and combination sodium sulfacetamide and sulfur commonly are used to treat rosacea. "
05/01/1979 - "The conjunctivitis responded rapidly to treatment with sodium sulfacetamide, and it was not treated systemically. "
06/01/1985 - "Topical sulfacetamide vs oral erythromycin for neonatal chlamydial conjunctivitis."
04/15/1985 - "An 8-year-old boy developed erythema multiforme major after topical administration of sodium sulfacetamide for conjunctivitis. "
06/01/1985 - "It was concluded that C trachomatis is the most frequent cause of neonatal conjunctivitis in the low-income, urban population studied; that erythromycin estolate administered orally for 14 days eradicates chlamydial conjunctival and nasopharyngeal infection; and that topical sulfacetamide therapy may result in persistent conjunctival infection and nasopharyngeal colonization."
09/01/1988 - "One hundred fifty-eight patients, 21 years of age or less, presenting with culture-positive (Haemophilus influenzae or Streptococcus pneumoniae) conjunctivitis were treated with trimethoprim-polymyxin B (TP), gentamicin sulfate (GS) or sodium sulfacetamide (SS) ophthalmic solution for 10 days. "
08/01/2015 - "Sodium sulfacetamide is effective in the management of a variety of inflammatory facial dermatoses and often is used in combination with sulfur for a synergistic effect. "
03/01/2010 - "The multifunctionality of 10% sodium sulfacetamide, 5% sulfur emollient foam in the treatment of inflammatory facial dermatoses."
06/01/2005 - "After 12 weeks of treatment with sodium sulfacetamide 10% and sulfur 5% cream with sunscreens, there was a significantly greater percentage reduction (80%) in inflammatory lesions compared with metronidazole 0.75% cream (72%)(P = .04), as well as a significantly greater percentage of subjects with improved erythema (69% vs 45%, respectively; P = .0007). "
07/15/1984 - "We studied trimethoprim in combination with sulfacetamide and polymyxin B and also in combination with polymyxin B alone (without the sulfacetamide) to determine the efficacy and safety of these new antibiotic combinations in the eyes of patients with bacterial conjunctivitis or blepharitis. "
07/15/1984 - "Trimethoprim-sulfacetamide-polymyxin B and polymyxin B-neomycin-gramicidin (Neosporin, the control) eliminated bacteria from the eyes of patients with conjunctivitis or blepharitis with equal effectiveness. "
|3.||azelaic acid (Azelex)
|5.||Polymyxin B (Aerosporin)
|7.||Gramicidin (Gramicidin A)
|8.||Sunscreening Agents (Sunscreens)
|9.||drug combination polymyxin B neomycin sulfate bacitracin zinc (Neosporin)